Literature DB >> 12019364

Future of melatonin as a therapeutic agent.

Michal Karasek1, Russel J Reiter, Daniel P Cardinali, Marek Pawlikowski.   

Abstract

Report of the round table conference summarizing the International Symposium on "Melatonin: Clinical Significance and Therapeutic Applications" is presented in this article. Some sleep disorders and circadian rhythm disturbances are the widely accepted indications for melatonin treatment. However, other possibilities for use of melatonin in the therapy should be also taken into account, including a co-treatment in cancer patients and free radical-related diseases. All aspects of the possible therapeutic use of melatonin as well as its safety, dosage, side effects and contraindications are discussed herein based on the round table conference and they are presented in this paper.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12019364

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  6 in total

Review 1.  Melatonin and its receptors: a new class of sleep-promoting agents.

Authors:  Karl Doghramji
Journal:  J Clin Sleep Med       Date:  2007-08-15       Impact factor: 4.062

2.  NMR and molecular dynamics studies of the interaction of melatonin with calmodulin.

Authors:  Adrián G Turjanski; Darío A Estrin; Ruth E Rosenstein; John E McCormick; Stephen R Martin; Annalisa Pastore; Rodolfo R Biekofsky; Vincenzo Martorana
Journal:  Protein Sci       Date:  2004-11       Impact factor: 6.725

3.  Melatonin and vitamin C administration ameliorate diazepam-induced oxidative stress and cell proliferation in the liver of rats.

Authors:  G H El-Sokkary
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

4.  Assessment of the Potential Role of Tryptophan as the Precursor of Serotonin and Melatonin for the Aged Sleep-wake Cycle and Immune Function: Streptopelia Risoria as a Model.

Authors:  Sergio D Paredes; Carmen Barriga; Russel J Reiter; Ana B Rodríguez
Journal:  Int J Tryptophan Res       Date:  2009-01-14

Review 5.  Melatonin in Alzheimer's disease.

Authors:  Li Lin; Qiong-Xia Huang; Shu-Sheng Yang; Jiang Chu; Jian-Zhi Wang; Qing Tian
Journal:  Int J Mol Sci       Date:  2013-07-12       Impact factor: 5.923

6.  Regulation of bone mass through pineal-derived melatonin-MT2 receptor pathway.

Authors:  Kunal Sharan; Kirsty Lewis; Takahisa Furukawa; Vijay K Yadav
Journal:  J Pineal Res       Date:  2017-06-20       Impact factor: 13.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.